Pular para conteúdo

Doença Falciforme

Gerenciamento da Crise de Oclusão Vascular e Síndrome Torácica Aguda

Manejo da dor

What is the best pharmacologic treatment for sickle cell disease pain crises? (abre nova janela)

Baker M, Hafner JW.

Fonte‎: Ann Emerg Med 2012;59(6):515-6.

Indexado‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (abre nova janela)

Update on pain management in sickle cell disease. (abre nova janela)

Ballas SK.

Fonte‎: Hemoglobin 2011;35(5-6):520-9.

Indexado‎: PubMed 21910604

DOI‎: 10.3109/03630269.2011.610478

https://www.ncbi.nlm.nih.gov/pubmed/21910604 (abre nova janela)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (abre nova janela)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Fonte‎: Thromb Haemost 2007;98(2):392-6.

Indexado‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (abre nova janela)

Terapia de hidratação (manejo de fluidos)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (abre nova janela)

Okomo U, Meremikwu MM.

Fonte‎: Cochrane Database Syst Rev 2012;(6):CD005406.

Indexado‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (abre nova janela)

Suplementação de Oxigênio

Guidelines for the management of the acute painful crisis in sickle cell disease. (abre nova janela)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Fonte‎: Br J Haematol 2003;120(5):744-52.

Indexado‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (abre nova janela)

Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease. (abre nova janela)

Stirnemann J, Letellier E, Aras N, Borne M, Brinquin L, Fain O.

Fonte‎: Diving Hyperb Med 2012;42(2):82-4.

Indexado‎: PubMed 22828815

https://www.ncbi.nlm.nih.gov/pubmed/22828815 (abre nova janela)

Terapia respiratória e antibiótica

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (abre nova janela)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Fonte‎: Hemoglobin 2004;28(2):85-102.

Indexado‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (abre nova janela)

Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. (abre nova janela)

Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL.

Fonte‎: N Engl J Med 1995;333(11):699-703.

Indexado‎: PubMed 7637747

DOI‎: 10.1056/NEJM199509143331104

https://www.ncbi.nlm.nih.gov/pubmed/7637747 (abre nova janela)

Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement. (abre nova janela)

Chang WL, Corate LM, Sinclair JM, van der Heyde HC.

Fonte‎: J Investig Med 2008;56(8):1023-7.

Indexado‎: PubMed 19050460

DOI‎: 10.2310/JIM.0b013e31818cb612

https://www.ncbi.nlm.nih.gov/pubmed/19050460 (abre nova janela)

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. (abre nova janela)

Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA.

Fonte‎: N Engl J Med 2000;342(25):1855-65.

Indexado‎: PubMed 10861320

DOI‎: 10.1056/NEJM200006223422502

https://www.ncbi.nlm.nih.gov/pubmed/10861320 (abre nova janela)